REGENXBIO
RGNX
$16.19
Share price
0.81%
Change (1 day)
-12.01%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.26 B
According to REGENXBIO's latest financial reports the company's total liabilities are $0.26 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | -17.3% |
| 2022-12-31 | $0.31 B | -9.31% |
| 2021-12-31 | $0.34 B | 5.81% |
| 2020-12-31 | $0.33 B | 592.53% |
| 2019-12-31 | $47.71 M | 36.45% |
| 2018-12-31 | $34.96 M | 123.45% |
| 2017-12-31 | $15.64 M | 42.32% |
| 2016-12-31 | $10.99 M | 140.49% |
| 2015-12-31 | $4.57 M | -50.24% |
| 2014-12-31 | $9.18 M | 97.49% |
| 2013-12-31 | $4.65 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -89.35% | 🇺🇸 USA |